Details for New Drug Application (NDA): 215576
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 215576
Tradename: | SUCRALFATE |
Applicant: | Amneal Pharms |
Ingredient: | sucralfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 215576
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCRALFATE | sucralfate | TABLET;ORAL | 215576 | ANDA | AvKARE | 42291-936 | 42291-936-90 | 90 TABLET in 1 BOTTLE (42291-936-90) |
SUCRALFATE | sucralfate | TABLET;ORAL | 215576 | ANDA | Amneal Pharmaceuticals NY LLC | 60219-1656 | 60219-1656-1 | 100 TABLET in 1 BOTTLE (60219-1656-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | Apr 15, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription